|
|
|
| Application progress of antidepressants in inflammatory bowel disease |
| DENG Minjuan1 ZHANG Wenkai1 SUN Na1 LAI Xinxiu1 WANG Xiang2 |
1.The Second Clinical Medical College, Lanzhou University, Gansu Province, Lanzhou 730000, China;
2.Department of Gastroenterology, Lanzhou University Second Hospital, Gansu Province, Lanzhou 730030, China |
|
|
|
|
Abstract Inflammatory bowel disease (IBD) is a chronic, recurrent, non-specific intestinal inflammatory disease. Its incidence is increasing year by year and the etiology is unknown. At present, there is no cure. The disease has characteristics of repeated attacks and prolonged, which brings great psychological burden to patients, and the risk of depression and anxiety is greatly increased. Research in recent years has shown that antidepressants can change the course of IBD patients and improve the prognosis. The mechanism of action may be to achieve anti-inflammatory and improve structure through brain-intestinal axis. This article reviews the relationship between antidepressants and IBD in order to promote the study of antidepressants in IBD.
|
|
|
|
|
|
[1] Mikocka-Walus A，Knowles SR，Keefer L，et al. Controversies Revisited：A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases [J]. Inflamm Bowel Dis，2016，22（3）：752-762.
[2] Fairbrass KM，Gracie DJ，Ford AC. Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 Years of Longitudinal Follow-Up [J]. Gastroenterology，2022，163（1）：190-203.e5.
[3] Persoons P，Vermeire S，Demyttenaere K，et al. The impact of major depressive disorder on the short-and long-term outcome of Crohn's disease treatment with infliximab [J]. Aliment Pharmacol Ther，2005，22（2）：101-110.
[4] Rao S，Schieber AMP，O’Connor CP，et al. Pathogen-Mediated Inhibition of Anorexia Promotes Host Survival and Transmission [J]. Cell，2017，168（3）：503-516.e12.
[5] Han Y，Zhao T，Cheng X，et al. Cortical Inflammation is Increased in a DSS-Induced Colitis Mouse Model [J]. Neurosci Bull，2018，34（6）：1058-1066.
[6] Enache D，Pariante CM，Mondelli V. Markers of central inflammation in major depressive disorder：A systematic review and meta-analysis of studies examining cerebrospinal fluid，positron emission tomography and post-mortem brain tissue [J]. Brain Behav Immun，2019，81：24-40.
[7] Stephansson O，Larsson H，Pedersen L，et al. Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden [J]. Inflamm Bowel Dis，2011，17（3）：795-801.
[8] Bear T，Dalziel J，Coad J，et al. The Microbiome-Gut-Brain Axis and Resilience to Developing Anxiety or Depression under Stress [J]. Microorganisms，2021，9（4）：723.
[9] Dupraz L，Magniez A，Rolhion N，et al. Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells [J]. Cell Rep，2021， 36（1）：109332.
[10] Dicks LMT，Hurn D，Hermanus D. Gut Bacteria and Neuropsychiatric Disorders [J]. Microorganisms，2021，9（12）：2583.
[11] Drossman DA，Tack J，Ford AC，et al. Neuromodulators for Functional Gastrointestinal Disorders（Disorders of Gut-Brain Interaction）：A Rome Foundation Working Team Report [J]. Gastroenterology，2018，154（4）：1140-1171.e1.
[12] Ladabaum U，Boyd E，Zhao WK，et al. Diagnosis，comorbidities，and management of irritable bowel syndrome in patients in a large health maintenance organization [J]. Clin Gastroenterol Hepatol，2012，10（1）：37-45.
[13] Mikocka-Walus A，Ford AC，Drossman DA. Antidepressants in inflammatory bowel disease [J]. Nat Rev Gastroenterol Hepatol，2020，17（3）：184-192.
[14] Fattahian E，Hajhashemi V，Rabbani M，et al. Anti-inflammatory Effect of Amitriptyline on Ulcerative Colitis in Normal and Reserpine-Induced Depressed Rats [J]. Iran J Ph- arm Res，2016，15（Suppl）：125-137.
[15] Daghaghzadeh H，Naji F，Afshar H，et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients：A double-blind controlled study [J]. J Res Med Sci，2015，20（6）：595-601.
[16] Kristensen MS，Kj?覸rulff TM，Ersb?覬ll AK，et al. The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study [J]. Inflamm Bowel Dis，2019，25（5）：886-893.
[17] Gracie DJ，Ford AC. Depression，Antidepressants，and Inflammatory Bowel Disease：Implications for Future Models of Care [J]. Gastroenterology，2019，156（8）：2345-2347.
[18] Yanartas O，Kani HT，Bicakci E，et al. The effects of psychiatric treatment on depression，anxiety，quality of life，and sexual dysfunction in patients with inflammatory bowel disease [J]. Neuropsychiatr Dis Treat，2016，12：673-683.
[19] Fairbrass KM，Costantino SJ，Gracie DJ，et al. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission：a systematic review and meta-analysis [J]. Lancet Gastroenterol Hepatol，2020，5（12）：1053-1062.
[20] Aziz I，Simrén M. The overlap between irritable bowel syndrome and organic gastrointestinal diseases [J]. Lancet Gastroenterol Hepatol，2021，6（2）：139-148.
[21] Fritsch P，Kolber MR，Korownyk C. Antidepressants for irritable bowel syndrome [J]. Can Fam Physician，2020，66（4）：265.
[22] 商伟芳，王启飞，李松霏，等.抗抑郁治疗在炎症性肠病中的应用[J].胃肠病学，2021，26（9）：560-563.
[23] Srinath AI，Walter C，Newara MC，et al. Pain management in patients with inflammatory bowel disease：insights for the clinician [J]. Therap Adv Gastroenterol，2012，5（5）：339- 357.
[24] Hutka P，Krivosova M，Muchova Z，et al. Association of Sleep Architecture and Physiology with Depressive Disorder and Antidepressants Treatment [J]. Int J Mol Sci，2021，22（3）：1333.
[25] Yu Y，Zhang G，Han T，et al. Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module [J]. BMC Complement Med Ther，2020，20（1）：199.
[26] Wang L，Wang R，Liu L，et al. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder：A systematic review and meta-analysis [J]. Brain Behav Immun，2019，79：24-38.
[27] Hafez HM，Ibrahim MA，Yehia Abdelzaher W，et al. Protective effect of mirtazapine against acetic acid-induced ulcerative colitis in rats：Role of NLRP3 inflammasome pathway [J]. Int Immunopharmacol，2021，101（Pt A）：108174.
[28] Iwata M，Ota KT，Li XY，et al. Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor [J]. Biological Psychiatry，2016，80（1）：12-22.
[29] Song Y，Zhao Y，Ma Y，et al. Biological functions of NLRP3 inflammasome：A therapeutic target in inflammatory bowel disease [J]. Cytokine Growth Factor Rev，2021，60：61-75.
[30] Liang C，Chen P，Tang Y，et al. Venlafaxine as an Adjuvant Therapy for Inflammatory Bowel Disease Patients With Anxious and Depressive Symptoms：A Randomized Controlled Trial [J]. Front Psychiatry，2022，13：880058.
[31] Lee M，Chang EB. Inflammatory Bowel Diseases（IBD）and the Microbiome-Searching the Crime Scene for Clues [J]. Gastroenterology，2021，160（2）：524-537. |
|
|
|
